Clinical Trial Update: Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy of ivabradine in patients with persistent atrial fibrillation and heart failure with reduced ejection fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Chun-Yao Huang | Conditions: Atrial Fibrillation, Ivabradine | Phase 3 | Status: UNKNOWN